{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

        
User account menu
Main navigation
  • Topics
    • Customer Care
    • Regulated Industries
    • Research & Tech
    • Quality Improvement Tools
    • People Management
    • Metrology
    • Manufacturing
    • Roadshow
    • QMS & Standards
    • Statistical Methods
    • Resource Management
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • Customer Care
    • Regulated Industries
    • Research & Tech
    • Quality Improvement Tools
    • People Management
    • Metrology
    • Manufacturing
    • Roadshow
    • QMS & Standards
    • Statistical Methods
    • Supply Chain
    • Resource Management
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Training

Leading Organizational Change Without a Road Map

How one company reinvented itself in the absence of a tried-and-true playbook

Austin Distel/Unsplash

Chengyi Lin
Bio
Michael Lee
Bio
Wed, 05/27/2026 - 12:01
  • Comment
  • RSS

Social Sharing block

  • Print
Body

Many leaderships teams staring down the barrel of organizational transformation face a similar dilemma: How do you take a leap into the unknown when there are no clear data, no well-trodden path to follow, and no assurance of success? What if the change you’re considering is uncharted territory, but waiting for certainty means standing still?

ADVERTISEMENT

Over the years, we’ve seen countless organizations struggle with these questions, whether they’re trying to flatten hierarchies, implement new processes, or change how decisions are made. Through our five-year study of a company we’ll call by the pseudonym Pharma Global (PG), we uncovered key insights into how executive teams can deftly navigate a high-stakes and uncertain transformation and move forward with conviction.

Trap 1: Overthinking the leap

Like its competitors, PG had long relied on a few blockbuster drugs. But by the 2010s, as a major acquisition expanded its R&D pipeline, its commercial team was managing an increasingly complex and expansive portfolio.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.

© 2026 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us